The therapeutic landscape for gastric/gastroesophageal junction (GEJ) cancers is ever-changing. This on-demand video features a dynamic discussion between a medical oncologist and pathologist diving into the most recent evidence-based recommendations for biomarker testing and new and emerging targeted therapies in G/GEJ. Experts will share insights into how biomarker results are shaping treatment selection and sequencing, highlighting the critical role of personalized medicine in improving outcomes. Don’t miss this opportunity to: See how your knowledge compares with that of other clinicians in interactive questions and case-based scenarios Download a convenient, point-of-care G/GEJ Cancers Biomarker Testing Resource designed to aid community oncologists and their care teams
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/expert-perspectives-new-emerging-biomarkers-targeted-therapy-options-g-gej
- Start Date: 2024-01-31 06:00:00
- End Date: 2024-01-31 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Astellas (Any division) - Amount: 85000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology